Journal of Thrombosis and Thrombolysis

Proceedings of the 13th National Conference on Anticoagulant Therapy

Anticoagulation therapy in 2015: where we are and where we are going

Jeffrey I. Weitz

Regulatory, legislative, and policy updates with anticoagulant use

John Fanikos, Leo F. Buckley, Ahmed Aldemerdash, Kimberly J. Terry, Gregory Piazza, Jean M. Connors, Samuel Z. Goldhaber

Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review

Adam Cuker, Holleh Husseinzadeh

Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatment

Charles E. Mahan

Managing unusual presentations of venous thromboembolism

Walter Ageno

Clinical significance and management of subsegmental pulmonary embolism

R. Ikesaka, M. Carrier

Inferior vena cava filters: current best practices

Anita Rajasekhar

Current antiplatelet agents: place in therapy and role of genetic testing

Eugene Yang

Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices

Lisa M. Baumann Kreuziger

New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?

Peter J. Kudenchuk

Predicting the risk of recurrent venous thromboembolism (VTE)

Michael B. Streiff

Thrombophilia: clinical–practical aspects

Stephan Moll

Role of thrombophilia testing: con

Scott M. Stevens

Aspirin in secondary prevention of recurrent venous thromboembolism

Kochawan Boonyawat, Mark A. Crowther

Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents

Deborah M. Siegal

Engaging with quality improvement in anticoagulation management

Geoffrey D. Barnes, Eva Kline-Rogers

Proceedings of the 13th National Conference on Anticoagulant Therapy